Identification of a novel de novo deletion mutation of desmin in a neonate with desminopathy

Authors

  • Nguyen Thi Huynh Nga Department of Biology, Dalat University, Da Lat, Viet Nam
  • Bui Chi Bao Functional Genomics Unit, DNA Medical Technology Company, Ho Chi Minh, Viet Nam; Department of Molecular Genetics, City Children’s Hospital, Ho Chi Minh, Viet Nam; School of Medicine, Vietnam National University, Hochiminh, Viet Nam
  • Nguyen Vuong Thao Vy Functional Genomics Unit, DNA Medical Technology Company, Ho Chi Minh, Viet Nam
  • Nguyen Manh Cong Functional Genomics Unit, DNA Medical Technology Company, Ho Chi Minh, Viet Nam
  • Nguyen Minh Hiep Center of Radiation Technology and Biotechnology, Nuclear Research Institute, DaLat, Viet Nam

DOI:

https://doi.org/10.15419/bmrat.v8i12.717

Keywords:

cardiomyopathy, cardiovascular, desmin, desminopathy, mutation, whole-exome sequencing

Abstract

Introduction: Whole-exome sequencing (WES), a high-throughput DNA sequencing method, has swiftly gained traction as a scalable approach for detecting novel de novo mutations and generating molecular diagnoses for genetic illnesses.

Case presentation: We describe a neonate girl with a novel de novo desmin (DES) variant. The patient was referred to our Department of Cardiology right after birth for multiple clinical cardiac and pulmonary presentations. Her family history was negative for cardiovascular diseases while her echocardiographic diagnosis indicated macrocardia, arrhythmia, ventricular septal defect (VSD) in association with tricuspid regurgitation. Electrocardiography showed prolonged QTc interval, premature atrial contractions following pulmonary arterial hypertension. The patient had a surgical VSD closure at the age of seven months. The healthy infant was fit enough to be discharged six weeks later. Whole-exome sequencing identified a novel de novo heterozygous frameshift deletion mutation p.E246VfsTer4 in DES gene. Among the variants detected, mutation in DES was predicted to be the only pathogenic one, causing desminopathy phenotype for the patient.

Conclusion: This report strengthens the genetic aetiology for desminopathy and highlights the need for screening an intriguing candidate, those who have the DES gene in congenital cardiovascular probands.

Published

2021-12-31

Issue

Section

Case report

How to Cite

Identification of a novel de novo deletion mutation of desmin in a neonate with desminopathy. (2021). Biomedical Research and Therapy, 8(12), 4809-4817. https://doi.org/10.15419/bmrat.v8i12.717

Similar Articles

1-10 of 75

You may also start an advanced similarity search for this article.